# The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response

> **NCT04653207** · NA · COMPLETED · sponsor: **Singapore Institute of Food and Biotechnology Innovation** · enrollment: 64 (actual)

## Conditions studied

- Type 2 Diabetes
- Obesity
- Pre Diabetes

## Interventions

- **OTHER:** Glucose Solution 1
- **OTHER:** Glucose Solution 2
- **OTHER:** Glucose Solution 3
- **OTHER:** Sucrose/Isomaltulose 100:0
- **OTHER:** Sucrose/Isomaltulose 0:100
- **OTHER:** Sucrose/Isomaltulose 50:50
- **OTHER:** Sucrose/Isomaltulose 60:40
- **OTHER:** Sucrose/Isomaltulose 70:30
- **OTHER:** Sucrose/Isomaltulose 80:20

## Key facts

- **NCT ID:** NCT04653207
- **Lead sponsor:** Singapore Institute of Food and Biotechnology Innovation
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-10-28
- **Final completion:** 2020-10-28
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04653207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04653207, "The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04653207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*